Melbārde-Gorkuša Inga, Irmejs Arvīds, Bērziņa Dace, Strumfa Ilze, Aboliņš Arnis, Gardovskis Andris, Subatniece Signe, Trofimovičs Genādijs, Gardovskis Jānis, Miklaševičs Edvīns
Hereditary Cancer Institute, Rīga Stradiņš University, Dzirciema Street 16, LV-1007 Riga, Latvia.
Hered Cancer Clin Pract. 2012 Apr 14;10(1):5. doi: 10.1186/1897-4287-10-5.
We would like to present a patient with a classical phenotype of a rare disorder - Cowden syndrome, its diagnostics and management challenges. A breast surgeon has to be aware of this rare condition when treating a patient with breast manifestations of Cowden syndrome and has to refer the patient to a clinical geneticist for further evaluation. Sequencing of the PTEN gene showed the Asp24Gly mutation. According to the latest literature data, the lifetime risk of breast cancer for Cowden syndrome patients is 81% and surgery is a justified option to reduce the risk of breast cancer. Bilateral risk-reducing mastectomy with immediate reconstruction was performed to eliminate further risk of breast cancer. 3 years after the risk-reducing breast surgery the patient is satisfied with the outcome. This is to our best knowledge the first reported Cowden syndrome case with follow-up data after risk-reducing measures have been taken.
我们想介绍一位患有罕见疾病——考登综合征经典表型的患者,及其诊断和管理挑战。乳腺外科医生在治疗有考登综合征乳腺表现的患者时必须了解这种罕见疾病,并必须将患者转介给临床遗传学家进行进一步评估。PTEN基因测序显示存在Asp24Gly突变。根据最新文献数据,考登综合征患者患乳腺癌的终生风险为81%,手术是降低乳腺癌风险的合理选择。进行了双侧预防性乳房切除术并立即进行重建,以消除患乳腺癌的进一步风险。在进行降低风险的乳房手术后3年,患者对结果感到满意。据我们所知,这是第一例报告的考登综合征病例,且有采取降低风险措施后的随访数据。